» Articles » PMID: 11485736

Crystal Structure of the IL-10/IL-10R1 Complex Reveals a Shared Receptor Binding Site

Overview
Journal Immunity
Publisher Cell Press
Date 2001 Aug 4
PMID 11485736
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin 10 (IL-10) is a dimeric cytokine that plays a central role in suppressing inflammatory responses. These activities are dependent on the interaction of IL-10 with its high-affinity receptor (IL-10R1). This intermediate complex must subsequently recruit the low-affinity IL-10R2 chain before cell signaling can occur. Here we report the 2.9 A crystal structure of IL-10 bound to a soluble form of IL-10R1 (sIL-10R1). The complex consists of two IL-10s and four sIL-10R1 molecules. Several residues in the IL-10/sIL-10R1 interface are conserved in all IL-10 homologs and their receptors. The data suggests that formation of the active IL-10 signaling complex occurs by a novel molecular recognition paradigm where IL-10R1 and IL-10R2 both recognize the same binding site on IL-10.

Citing Articles

Engineered chimeric receptors for dissecting interferon signaling.

Lin A, Mesev E, Toettcher J, Ploss A J Virol. 2024; 98(10):e0168023.

PMID: 39291974 PMC: 11495025. DOI: 10.1128/jvi.01680-23.


Interferon-Regulated Expression of Cellular Splicing Factors Modulates Multiple Levels of HIV-1 Gene Expression and Replication.

Roesmann F, Muller L, Klaassen K, Hess S, Widera M Viruses. 2024; 16(6).

PMID: 38932230 PMC: 11209495. DOI: 10.3390/v16060938.


Structural insights into IL-11-mediated signalling and human IL6ST variant-associated immunodeficiency.

Gardner S, Jin Y, Fyfe P, Voisin T, Bellon J, Pohler E Nat Commun. 2024; 15(1):2071.

PMID: 38453915 PMC: 10920896. DOI: 10.1038/s41467-024-46235-6.


Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology.

Elemam N, Mekky R, Rashid G, Braoudaki M, Youness R Expert Rev Mol Med. 2024; 26:e1.

PMID: 38186186 PMC: 10941350. DOI: 10.1017/erm.2023.26.


Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation.

Mesev E, Guare E, Ploss A, Toettcher J J Interferon Cytokine Res. 2023; 43(9):414-426.

PMID: 37725008 PMC: 10517332. DOI: 10.1089/jir.2023.0039.